BioSpace News Archive

Press Releases

Silver Creek Pharmaceuticals Receives FDA Fast Track Designation for Scp776 in Acute Ischemic Stroke

October 20, 2025
·
2 min read
Press Releases

IMFINZI® (durvalumab) regimen reduced the risk of disease recurrence or death by 32% in high-risk non-muscle-invasive bladder cancer in the POTOMAC Phase III trial

October 20, 2025
·
19 min read
Press Releases

IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial

October 20, 2025
·
19 min read
Press Releases

Boehringer’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC

October 20, 2025
·
8 min read
Press Releases

Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025

October 20, 2025
·
7 min read
Press Releases

Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia

October 20, 2025
·
4 min read
Press Releases

ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025

October 20, 2025
·
3 min read
Press Releases

Savara Announces Chief Medical Officer (CMO) Transition

October 20, 2025
·
5 min read
Press Releases

Artios Announces Phase 1/2a Data for DNA Polymerase Theta Inhibitor ART6043 at ESMO Congress 2025

October 20, 2025
·
4 min read
Press Releases

Wobble Genomics Presents Latest Data at ESMO: establishing the robustness of an enhanced liquid biopsy platform for sensitive detection of low-abundance RNA

October 20, 2025
·
2 min read